Synthesis and biological evaluation of nitric oxide-releasing matrine derivatives as anticancer agents

Chinese Chemical Letters

Volumn 21, Issue 4, 2010, Pages 381-384

  He, Li Qin ^a,b   Liu, Jing ^b   Yin, Deng Ke ^b   Zhang, Yi Hua ^a   Wang, Xiao Shan ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Anti tumor activity; Furoxan; HepG2; Matrine

Indexed keywords

EID: 76349084918     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cclet.2009.11.033     Document Type: Article

References (18)

1. Zhao B.G. Yaoxue Xuebao 15 (1980) 182
2. Cho C.H., Chuang C.Y., and Chen C.F. Planta Med. 52 (1986) 343
3. Tao S.C., and Wang J.Z. Acta Pharmacol. Sin. 27 (1992) 201
4. Ai J., Gao H.H., He S.Z., et al. Acta Pharmacol. Sin. 22 (2001) 512
5. Zhang J.P., Zhang M., Zhou J.P., et al. Acta Pharmacol. Sin. 22 (2001) 183
6. Xu X.R., and Jiang J.K. Chin. J. Integr. Trad. Chin. West. Med. 4 (1998) 235
7. Chui C.H., Lau F.Y., Tang J.C., et al. Int. J. Mol. Med. 16 (2005) 337
8. Hu M.J., Zeng H., Wu Y.L., et al. Chin. J. Dig. Dis. 6 (2005) 68
9. Cheng X.D., Du Y., Huang L., et al. Chinese-German J. Clin. Oncol. 7 4 (2008) 213
10. Tarr J.M., Eggleton P., and Winyard P.G. Curr. Pharm. Des. 12 (2006) 4445
11. Mitra R., Singh S., and Khar A. Expert Rev. Mol. Med. 13 (2003) 1
12. Hou Y.C., Janczuk A., and Wang P.G. Curr. Pharm. Des. 5 (1999) 417
13. Wang P.G., Xian M., Tang X., et al. Chem. Rev. 102 (2002) 1091
14. Kerwin J.J., and Heller M. Med. Res. Rev. 14 1 (1994) 23
15. Jia Q., Janczuk A.J., Cai T., et al. Expert Opin. Ther. Pat. 12 (2002) 819
16. Medana C., DiStilo A., Visentin S., et al. Pharm. Res. 16 (1999) 956
17. 6S: C 61.64, H 6.58, N 11.24; found: C 61.12, H 6.74, N 10.89.
18. Moreira D.R.M., Leite A.C.L., Ferreira D.M.P., et al. Eur. J. Med. Chem. 42 3 (2007) 351